参考文献/References:
[1] Haugen BR, Alexander EK, Bible KC,et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer[J].Thyroid,2016,26(1):1-133. DOI:10.1089/thy.2015.0020.
[2] Francis GL,Waguespack SG,Bauer AJ,et al.Management guidelines for children with thyroid nodules and differentiated thyroid cancer[J].Thyroid,2015,25(7):716-759.DOI:10.1089/thy.2014.0460.
[3] Ali SZ, Cibas ES. The Bethesda system for reporting thyroid cytopathology:definitions, criteria and explanatory notes[M]. New York:Springer, 2017,27.
[4] Nikiforov YE,Seethala RR,Tallini G,et al. Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma:a paradigm shift to reduce overtreatment of indolent tumors[J].JAMA Oncol,2016,2(8):1023-1029. DOI:10.1001/jamaoncol.2016.0386.
[5] Amendoeira I,Maia T,Sobrinho-Simo～es M.Non-invasive follicular thyroid neoplasm with papillary-like nuclear features(NIFTP): impact on the reclassification of thyroid nodules[J].Endocr Relat Cancer,2018,25(4):R247-R258.DOI:10.1530/ERC-17-0513.
[6] Bongiovanni M,Giovanella L,Romanelli F,et al.Cytological diagnoses associated with noninvasive follicular thyroid neoplasms with papillary-like nuclear features according to the Bethesda system for reporting thyroid cytopathology: a systematic review and meta-analysis[J].Thyroid,2019,29(2):222-228. DOI:10.1089/thy.2018.0394.
[7] Cibas ES, Ali SZ. The Bethesda system for reporting thyroid cytopathology[J].Thyroid,2009,19(11):1159-1165.
[8] Bongiovanni M,Spitale A,Faquin WC,et al. The Bethesda system for reporting thyroid cytopathology: a meta-analysis[J].Acta Cytol,2012,56(4):333-339.DOI:10.1159/000339959.
[9] 刘晓云,蔡赟,陈欢欢,等.Bethesda细胞病理报告系统在甲状腺细针穿刺中的应用[J]. 南京医科大学学报(自然科学版),2015,35(12):1718-1721.DOI:10.7655/NYDXBNS20151210.
[10] 严佳梅,黄品同,游向东,等.超声造影结合细针穿刺对甲状腺癌的诊断价值[J]. 中华超声影像学杂志,2014,23(3):222-226.DOI:10.3760/cma.j.issn.1004-4477.2014.03.016.
[11] Gao LY,Wang Y,Jiang YX,et al. Ultrasound is helpful to differentiate Bethesda class Ⅲ thyroid nodules: a PRISMA-compliantsystematic review and meta-analysis[J].Medicine(Baltimore),2017,96(16):e6564.DOI:10.1097/MD.0000000000006564.
[12] Kuru B,Kefeli M.Risk factors associated with malignancy and with triage to surgery in thyroid nodules classifiedas Bethesda category Ⅳ(FN/SFN)[J].Diagn Cytopathol,2018,46(6):489-494. DOI:10.1002/dc.23923.
[13] Sacks WL,Bose S,Zumsteg ZS,et al.Impact of Afirma gene expression classifier on cytopathology diagnosis and rate of thyroidectomy[J].Cancer Cytopathol,2016,124(10):722-728.DOI:10.1002/cncy.21749.
[14] Maia FF,Matos PS,Pavin EJ,et al.Thyroid imaging reporting and data system score combined with Bethesda system for malignancy risk stratification in thyroid nodules with indeterminate results on cytology[J].Clin Endocrinol(Oxf),2015,82(3):439-444.DOI:10.1111/cen.12525.
[15] 周一帆,季沁,陈国芳,等.TI-RADS对细胞学结果不确定甲状腺结节的诊断价值[J]. 国际内分泌代谢杂志,2019, 39(4):226-230. DOI:10.3760/cma.j.issn.1673-4157.2019.04.003.
[16] Zhang YZ,Xu T,Cui D,et al. Value of TIRADS, BSRTC and FNA-BRAF V600E mutation analysis in differentiating high-riskthyroid nodules[J].Sci Rep,2015,5:16927. DOI:10.1038/srep16927.
[17] Mao F,Xu HX,Zhao CK,et al.Thyroid imaging reporting and data system in assessment of cytological Bethesda Category Ⅲ thyroid nodules[J].Clin Hemorheol Microcirc,2017,65(2):163-173.DOI:10.3233/CH-16146.
[18] He YP,Xu HX,Zhao CK,et al. Cytologically indeterminate thyroid nodules: increased diagnostic performance with combinationof US TI-RADS and a new scoring system[J].Sci Rep,2017,7(1):6906.DOI:10.1038/s41598-017-07353-y.
[19] Trimboli P,Fulciniti F,Zilioli V,et al. Accuracy of international ultrasound risk stratification systems in thyroid lesions cytologically classified as indeterminate[J].Diagn Cytopathol,2017,45(2):113-117.DOI:10.1002/dc.23651.
[20] Trimboli P,Giovanella L.Reliability of core needle biopsy as a second-line procedure in thyroid nodules with an indeterminate fine-needle aspiration report:a systematic review and meta-analysis[J].Ultrasonography,2018,37(2):121-128. DOI:10.14366/usg.17066.
[21] Li XJ,Mao XD,Chen GF,et al.High BRAFV600E mutation frequency in Chinese patients with papillary thyroid carcinoma increases diagnostic efficacy in cytologically indeterminate thyroid nodules[J].Medicine(Baltimore),2019,98(28):e16343.DOI:10.1097/MD.0000000000016343.
相似文献/References:
[1]杨成会,缪珩.二甲双胍在甲状腺疾病治疗中的作用[J].国际内分泌代谢杂志,2015,(04):255.[doi:10.3760/cma.j.issn.1673-4157.2015.04.011]
Yang Chenghui,Miao Heng..Roles of metformin in the treatment of thyroid diseases[J].International Journal of Endocrinology and Metabolism,2015,(03):255.[doi:10.3760/cma.j.issn.1673-4157.2015.04.011]
[2]梁绮君 余寿益 李淑华 胡晨鸣 杨焱.甲状腺结节与代谢综合征的相关性研究[J].国际内分泌代谢杂志,2015,(05):293.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.002]
Liang Qijun,Yu Shouyi,Li Shuhua,et al.Association of thyroid nodule and metabolic syndrome[J].International Journal of Endocrinology and Metabolism,2015,(03):293.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.002]
[3]郑仁东 张会峰 胡咏新 曹雯 曹琳 孙洪平 褚晓秋 刘克冕 刘超.男性2型糖尿病患者甲状腺结节
与内分泌激素的相关性研究[J].国际内分泌代谢杂志,2018,38(04):222.[doi:10.3760/cma.j.issn.1673-4157.2018.04.002]
Zheng Rendong,Zhang Huifeng,Hu Yongxin,et al.Association of thyroid nodules with endocrine hormones in male patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2018,38(03):222.[doi:10.3760/cma.j.issn.1673-4157.2018.04.002]
[4]陈茉 徐书杭 刘超.良性甲状腺结节的热消融治疗进展[J].国际内分泌代谢杂志,2019,39(04):248.[doi:10.3760/cma.j.issn.1673-4157.2019.04.008]
Chen Mo,Xu Shuhang,Liu Chao.Advancement of thermal ablation on benign thyroid nodules[J].International Journal of Endocrinology and Metabolism,2019,39(03):248.[doi:10.3760/cma.j.issn.1673-4157.2019.04.008]
[5]周一帆 季沁 陈国芳 褚晓秋 陈茉 丁文波 胡欣 相萍萍 曾铮 王建华 徐书杭 刘超.TI-RADS对细胞学结果不确定甲状腺结节的诊断价值[J].国际内分泌代谢杂志,2019,39(04):226.[doi:10.3760/cma.j.issn.1673-4157.2019.04.003]
Zhou Yifan,Ji Qin,Chen Guofang,et al.Clinical value of TI-RADS in the diagnosis of thyroid nodules with indeterminate cytology[J].International Journal of Endocrinology and Metabolism,2019,39(03):226.[doi:10.3760/cma.j.issn.1673-4157.2019.04.003]
[6]杨晶晶,徐书杭,刘超.针穿活检用于甲状腺结节诊断的研究进展[J].国际内分泌代谢杂志,2021,41(01):20.[doi:10.3760/cma.j.cn121383-20200511-05018]
Yang Jingjing,Xu Shuhang,et al.Update on core needle biopsy in the diagnosis of thyroid nodules[J].International Journal of Endocrinology and Metabolism,2021,41(03):20.[doi:10.3760/cma.j.cn121383-20200511-05018]
[7]田勍,洪天配.甲状腺结节诊治过程中的难点与应对[J].国际内分泌代谢杂志,2021,41(06):557.[doi:10.3760/cma.j.cn121383-20210727-07074]
Tian Qing,Hong Tianpei..Difficulties and countermeasures in the diagnosis and treatment of thyroid nodules[J].International Journal of Endocrinology and Metabolism,2021,41(03):557.[doi:10.3760/cma.j.cn121383-20210727-07074]
[8]张雅,相萍萍,徐书杭,等.经皮无水乙醇注射治疗甲状腺结节:老方法的新认识[J].国际内分泌代谢杂志,2022,42(06):469.[doi:10.3760/cma.j.cn121383-20210926-09075]
Zhang Ya,Xiang Pingping,Xu Shuhang,et al.Percutaneous ethanol ablation for thyroid nodules: new perspectives on an old paradigm[J].International Journal of Endocrinology and Metabolism,2022,42(03):469.[doi:10.3760/cma.j.cn121383-20210926-09075]
[9].甲状腺结节和分化型甲状腺癌诊治指南(第二版)[J].国际内分泌代谢杂志,2023,43(02):149.[doi:10.3760/cma.j.cn311282-20221023-00589]
Chinese Society of Endocrinology,Thyroid and Metabolism Surgery Group of the Chinese Society of Surgery,China Anti-Cancer Association,et al.Guidelines for the Diagnosis and Management of Thyroid Nodules and Differentiated Thyroid Cancer(Second Edition)[J].International Journal of Endocrinology and Metabolism,2023,43(03):149.[doi:10.3760/cma.j.cn311282-20221023-00589]
[10]李春睿,马金友,徐书杭,等.甲状腺结节与结直肠息肉的相关性及可能机制[J].国际内分泌代谢杂志,2023,43(04):333.[doi:10.3760/cma.j.cn121383-20220327-03065]
Li Chunrui,Ma Jinyou,Xu Shuhang,et al.Correlation and possible mechanism between thyroid nodules and colorectal polyps[J].International Journal of Endocrinology and Metabolism,2023,43(03):333.[doi:10.3760/cma.j.cn121383-20220327-03065]